Coronavirus (COVID-19): Latest Updates | Visitation PoliciesVisitation PoliciesVisitation PoliciesVisitation PoliciesVisitation Policies | COVID-19 Testing | Vaccine InformationVaccine InformationVaccine Information
Wilmot is a leader in cancer research and here's why:
Investigators work in three multidisciplinary, collaborative programs that study cancer biology, the tumor microenvironment, and toxicities and side effects of cancer and its treatment.
Wilmot has nearly 100 dedicated scientists from 25 academic departments across the University of Rochester who are devoted to studying cancer.
Shared Resources provide cost-effective access to state-of-the art technologies, expert guidance and training, and scientific consultation for Wilmot researchers.
Clinical trials are the backbone of cancer research, identifying better and safer treatments for patients.
Wilmot offers a variety of intramural funding mechanisms to support cancer researchers, as well as resources for extramural funding.
A community of scientists investigating how cancer occurs, and better ways to prevent, diagnosis, and treat cancer and its side effects.